The presentation should give clinicians a better look at the data, said SEAS steering committee chair Dr Terje Pedersen, and provide more information about the end points and the incidence of clinical events in patients, as well as information on the incidence and types of cancer observed in the trial. Heartwire
An improved cardiac MR protocol, using T2-weighted imaging and LV assessment, can differentiate between new and old MI and provide information over and above clinical assessment and traditional cardiac risk factors, researchers say. Heartwire
Antiretroviral drugs for HIV infection do not increase the risk of coronary atherosclerosis, a new study has found. The results should reassure doctors who have been concerned about this, say the researchers. Heartwire
Another study has found that that low levels of low 25-hydroxyvitamin D levels seem to be linked to an increased risk for death, this time in a nationally representative cohort. Medscape Medical News
Being obese does not always mean that a patient has other risk factors for heart disease, 2 studies show; it all depends on where the excess fat is stored, with liver fat having the worst profile. Medscape Medical News
US doctors have reported the first experiences of heart transplant in three infants after cardiac death in the donors, rather than brain death. The controversial procedure "has opened the door to heart transplant after cardiac death," says an accompanying perspective. Heartwire
Due to concern about a possible link between bisphosphonates and cardiac arrhythmias, an observational study looked at whether alendronate use is related to incident atrial fibrillation risk in women. The North American Menopause Society (NAMS)
The challenge will not be in acquiring a prehospital electrocardiogram but rather using and integrating the diagnostic information obtained by emergency medical services into existing systems of care. Medscape Medical News
The relief from angina and a better quality of life provided by percutaneous coronary intervention–based management in a controversial trial was modest and temporary, some observers say. Medscape Medical News